Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents.

Fiche publication

Date publication

avril 2022

Journal

Journal of the American Geriatrics Society

Auteurs

Membres identifiés du Cancéropôle Est :
Dr JEULIN Hélène

Tous les auteurs :
Jeulin H, Labat C, Duarte K, Toupance S, Nadin G, Craus D, Georgiopoulos I, Gantois I, Goehringer F, Benetos A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35484977

Résumé

Duration of post-vaccination protection against COVID-19 in nursing home (NH) residents is a critical issue. The objective of this study was to estimate the duration of the IgG(S) response to the mRNA BNT162b2 vaccine in NH residents with (COV-Yes) or without (COV-No) history of SARS-CoV-2 infection.